Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
MRNA - Moderna, Inc.
Market Cap 42.02B P/E 9.48 EPS this Y 42.90% Ern Qtrly Grth -
Income -5.97B Forward P/E -27.08 EPS next Y 25.00% 50D Avg Chg -11.00%
Sales 5.15B PEG 0.36 EPS past 5Y - 200D Avg Chg -27.00%
Dividend N/A Price/Book 2.24 EPS next 5Y -51.34% 52W High Chg -49.00%
Recommedations 2.50 Quick Ratio 3.74 Shares Outstanding 383.24M 52W Low Chg -
Insider Own 9.59% ROA -15.72% Shares Float 346.03M Beta 1.57
Inst Own 74.76% ROE -37.68% Shares Shorted/Prior 21.07M/21.44M Price 110.22
Gross Margin -70.27% Profit Margin -115.82% Avg. Volume 3,254,514 Target Price 137.59
Oper. Margin -758.08% Earnings Date Aug 1 Volume 4,434,575 Change -3.26%
Healthcare | Biotechnology | United States
About Moderna, Inc.

Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, autoimmune, and cardiovascular diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, influenza, and respiratory syncytial virus, spikevax, and hMPV/PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella zoster virus, and human immunodeficiency virus vaccines; public health vaccines consists of Zika, Nipah, Mpox vaccines; and infectious diseases vaccines, such as lyme and norovirus vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; rare disease intracellular therapeutics; and inhaled pulmonary therapeutics. It has strategic alliances and collaborations with AstraZeneca; Merck & Co., Inc; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Chiesi Farmaceutici S.p.A.; Metagenomi, Inc.; Carisma Therapeutics, Inc.; CytomX Therapeutics; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; The Bill & Melinda Gates Foundation; and OpenAI. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.

Moderna, Inc. News
05/14/24 Moderna Stock Rebounds From Its RSV Vaccine Fallout — Is It A Buy, Again?
05/14/24 Is This a Setback for Moderna?
05/13/24 Moderna (MRNA) Falls as FDA Extends Review Time for RSV Vaccine
05/13/24 While shareholders of Moderna (NASDAQ:MRNA) are in the black over 5 years, those who bought a week ago aren't so fortunate
05/13/24 Company News For May 13, 2024
05/13/24 Investors Heavily Search Moderna, Inc. (MRNA): Here is What You Need to Know
05/13/24 Bull Market and Beyond: 2 Stocks Just Waiting to Soar
05/13/24 Moderna to Present at Upcoming Conferences in May/June 2024
05/12/24 Moderna and OpenAI Are Teaming Up, but Does That Make the Stock a Buy?
05/10/24 Novavax stock doubles after Sanofi deal marks 'new chapter' for company
05/10/24 Moderna Tumbles After The FDA Throws A Curveball On Its Second Product
05/10/24 Consumer sentiment drops, Tesla's Supercharger, Zeekr IPO: Catalysts
05/10/24 Top Midday Stories: Biden to Reportedly Quadruple Chinese EV Tariffs; Novavax Shares Soar on Sanofi Deal News; Protesters Try to Break Into Tesla's Plant in Germany; FDA Pushes Back Approval of Moderna Vaccine
05/10/24 Moderna: FDA postpones RSV vaccine approval
05/10/24 Moderna's RSV Vaccine Review Delayed by FDA to End of May
05/10/24 FDA Delays Decision on Moderna RSV Shot by 3 Weeks
05/10/24 FDA delays decision on Moderna RSV vaccine
05/10/24 US FDA pushes decision on Moderna's RSV vaccine to end of this month
05/10/24 Moderna Announces Update on Investigational RSV Vaccine
05/09/24 Moderna's Promise of mRNA Undercut by New RSV Vaccine
MRNA Chatroom

User Image taxplanr Posted - 3 minutes ago

$MRNA leadership? why worry? https://x.com/StarkNakedBrief/status/1790827032412057915

User Image Benroxx Posted - 11 minutes ago

$MRNA Novavax: Call it a comeback Yeah

User Image Benroxx Posted - 12 minutes ago

$MRNA hi https://stocktwits.com/Lazarus2024/message/573116855

User Image framus_morrigan Posted - 2 hours ago

$MRNA Early monthly chart update. On its way to its first target

User Image axelvento999 Posted - 6 hours ago

$MRNA two weeks before approval....tic toc

User Image taxplanr Posted - 8 hours ago

Nanobots programming humanity thanks to $MRNA $BNTX $PFE https://madmaxworld.tv/watch?id=6643f3e2684fe5289a959215

User Image taxplanr Posted - 11 hours ago

So here is the PubMed on those Molecular Jackhammers that make the IoB nano lipids from $MRNA $BNTX $PFE Obsolete https://pubmed.ncbi.nlm.nih.gov/38114816/

User Image brs555 Posted - 13 hours ago

Yep. Great nut shell interpretation. Jury comes to the same conclusion...Discovery in a month. Trial a year away. $ROIV given a $5.2 billion carrot by Pfizer. $MRNA is out! Paying damages to Pfizer after $ABUS $PFE agree to some sort of buyout. Pfizer smelling like roses. Brilliant. Matt Gline smells even better! JMHO

User Image goupdarnit Posted - 13 hours ago

$MRNA this will easily be a 500 dollar stock

User Image vinmee Posted - 13 hours ago

$IOVA their sales and buyout will skyrocket $AZTA $LLY $MRNA

User Image MrsBelfort Posted - 14 hours ago

$MRNA $PFE $AZN For these big pharma, potential acquisition candidates for their due diligence teams to look at: $CADL $CAPR Candel is getting expensive but Capricor is still quite cheap.

User Image bearishbull710 Posted - 14 hours ago

$NVAX $MRNA $PFE $BNTX will FDA pick JN.1 over FLIRTs on 06/05 despite the tiny share? https://x.com/CDCgov/status/1790813172040888584

User Image taxplanr Posted - 14 hours ago

$MRNA $BNTX $PFE will probably not be sponsoring this channel https://x.com/HOPEGIRLBLOG/status/1790187837817573634

User Image taxplanr Posted - 14 hours ago

Brought to you with the help of $MRNA $BNTX $PFE https://x.com/JeffreyJMatte/status/1790377046134120887

User Image DojiDaddy Posted - 17 hours ago

$MRNA $PFE $BNTX

User Image taxplanr Posted - 17 hours ago

$MRNA $BNTX $PFE

User Image smartkarma Posted - 17 hours ago

$MRNA | Moderna Inc.: Progress in Personalized Cancer Vaccine (PCV) Manufacturing & Other Major Developments "Moderna Inc.'s first quarter 2024 financial results and business updates indicate a positive forward motion in the development of its business and..." - Baptista Research (Baptista Research) Key Points:Moderna Inc.'s first quarter 2024 financial results and business updates indicate a positive forward motion in the development of its business and vaccines.The company's COVID vaccines have impacted hundreds of millions of people and through ongoing Phase III studies, Moderna expects its vaccinations to impact many more.In the first quarter, the company made substantial clinical progress with data presentation on Epstein-Barr virus (EBV), Varicella Zoster Virus (VZV), and Norovirus. Read more: https://www.smartkarma.com/insights/moderna-inc-progress-in-personalized-cancer-vaccine-pcv-manufacturing-other-major-developments

User Image taxplanr Posted - 19 hours ago

$MRNA $BNTX $PFE $MRK the Cancer industry will probably end up being just add Ivermectin and/or Fenbendazole for safe effective cancer treatments

User Image MrDuster Posted - 20 hours ago

$MRNA hanging on mercy of market makers, they about to drop this baby 20 bucks in couple of days. $QQQ $SPY

User Image MrDuster Posted - 20 hours ago

$SPY easy puts $MRNA

User Image taxplanr Posted - 21 hours ago

It's like a black Swann for the man made nano lipids from $MRNA $BNTX $PFE

User Image srigurukkal Posted - 22 hours ago

$MRNA why s it down

User Image georgeyann Posted - 1 day ago

$MRNA ask yourself one question before you hold $mrna: are you going to take another booster shot or any other poison mrna vaccine?

User Image georgeyann Posted - 1 day ago

$MRNA strong

User Image axelvento999 Posted - 1 day ago

$MRNA A potential approval will also show that Moderna isn't just a one-product company and instead can build a billion-dollar respiratory vaccine portfolio, including several game-changing products.

User Image taxplanr Posted - 1 day ago

This might not be good for $MRNA $BNTX $PFE https://open.substack.com/pub/anitabaxasmd/p/encouraging-news-from-the-alternativeintegrative?utm_campaign=post&utm_medium=web

User Image Newyork_ Posted - 1 day ago

$MRNA

User Image daduriver Posted - 1 day ago

$MRNA ??

User Image taxplanr Posted - 1 day ago

$MRNA Do you understand the science that the competition uses to cure Melanomas? "Near-infrared light can penetrate far deeper into the body than visible light, accessing organs or bones without damaging tissue."

User Image taxplanr Posted - 1 day ago

$MRNA as far as nanobot medicines for curing cancer and especially melanoma goes no man made lipids are needed https://news.rice.edu/news/2023/molecular-jackhammers-good-vibrations-eradicate-cancer-cells

Analyst Ratings
Evercore ISI Group In-Line May 14, 24
UBS Buy May 7, 24
Canaccord Genuity Hold May 3, 24
RBC Capital Outperform May 3, 24
Oppenheimer Outperform May 3, 24
Needham Hold May 2, 24
Needham Hold Apr 11, 24
Jefferies Buy Apr 9, 24
RBC Capital Outperform Mar 28, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Hoge Stephen President President Dec 27 Sell 100.01 45,000 4,500,450 1,531,063 12/28/23
Klinger Shannon Thyme Chief Legal Officer Chief Legal Officer Dec 07 Sell 79.09 563 44,528 7,912 12/11/23
AFEYAN NOUBAR Director Director Nov 01 Sell 75.73 10,000 757,300 2,146,931 11/03/23
AFEYAN NOUBAR Director Director Oct 25 Sell 77.49 10,000 774,900 2,156,931 10/27/23
AFEYAN NOUBAR Director Director Oct 11 Sell 104.26 15,000 1,563,900 2,166,931 10/13/23
Mock James M Chief Financial Offi.. Chief Financial Officer Oct 05 Sell 102.5 2,858 292,945 2,952 10/10/23
AFEYAN NOUBAR Director Director Oct 04 Sell 102.05 15,000 1,530,750 2,181,931 10/06/23
AFEYAN NOUBAR Director Director Sep 27 Sell 99.37 10,000 993,700 2,196,931 09/29/23
AFEYAN NOUBAR Director Director Sep 20 Sell 104.9 15,000 1,573,500 2,206,931 09/22/23
AFEYAN NOUBAR Director Director Sep 13 Sell 111.17 15,000 1,667,550 2,221,931 09/15/23
AFEYAN NOUBAR Director Director Sep 06 Sell 108.08 15,000 1,621,200 1,982,209 09/08/23
Garay Arpa Chief Commercial Off.. Chief Commercial Officer Sep 05 Sell 108.4 574 62,222 3,113 09/07/23
AFEYAN NOUBAR Director Director Aug 30 Sell 115.96 15,000 1,739,400 1,997,209 09/01/23
AFEYAN NOUBAR Director Director Aug 23 Sell 114.78 15,000 1,721,700 2,012,209 08/25/23
AFEYAN NOUBAR Director Director Aug 16 Sell 97.71 10,000 977,100 2,027,209 08/18/23
Hoge Stephen President President Aug 17 Sell 100.00 15,000 1,500,000 1,587,579 08/18/23
AFEYAN NOUBAR Director Director Aug 02 Sell 112.08 15,000 1,681,200 2,037,209 08/04/23
AFEYAN NOUBAR Director Director Jul 26 Sell 120.47 15,000 1,807,050 2,052,209 07/28/23
AFEYAN NOUBAR Director Director Jul 19 Sell 125.16 15,000 1,877,400 2,067,209 07/21/23
AFEYAN NOUBAR Director Director Jul 12 Sell 125.9 15,000 1,888,500 2,082,209 07/14/23
AFEYAN NOUBAR Director Director Jul 05 Sell 125.84 15,000 1,887,600 2,097,209 07/07/23
AFEYAN NOUBAR Director Director Jun 28 Sell 121.33 15,000 1,819,950 2,112,209 06/30/23
AFEYAN NOUBAR Director Director Jun 21 Sell 122.45 15,000 1,836,750 2,127,209 06/23/23
AFEYAN NOUBAR Director Director Jun 14 Sell 126.73 15,000 1,900,950 2,142,209 06/16/23
AFEYAN NOUBAR Director Director Jun 07 Sell 126.17 15,000 1,892,550 2,157,209 06/09/23
Garay Arpa Chief Commercial Off.. Chief Commercial Officer Jun 05 Sell 125.75 2,290 287,968 2,547 06/07/23
AFEYAN NOUBAR Director Director May 31 Sell 127.7 15,000 1,915,500 2,172,209 06/02/23
Bancel Stephane Chief Executive Offi.. Chief Executive Officer Apr 26 Sell 131.62 80,000 10,529,600 5,411,946 04/28/23
Bancel Stephane Chief Executive Offi.. Chief Executive Officer Apr 26 Option 0.99 80,000 79,200 5,451,946 04/28/23
Bancel Stephane Chief Executive Offi.. Chief Executive Officer Apr 19 Sell 142.81 80,000 11,424,800 5,411,946 04/21/23
Bancel Stephane Chief Executive Offi.. Chief Executive Officer Apr 19 Option 0.99 80,000 79,200 5,451,946 04/21/23
Bancel Stephane Chief Executive Offi.. Chief Executive Officer Apr 05 Sell 155.78 80,000 12,462,400 5,411,946 04/07/23
Bancel Stephane Chief Executive Offi.. Chief Executive Officer Apr 05 Option 0.99 80,000 79,200 5,451,946 04/07/23
Bancel Stephane Chief Executive Offi.. Chief Executive Officer Mar 22 Sell 150.21 80,000 12,016,800 5,411,946 03/24/23
Bancel Stephane Chief Executive Offi.. Chief Executive Officer Mar 22 Option 0.99 80,000 79,200 5,451,946 03/24/23
AFEYAN NOUBAR Director Director Mar 01 Sell 139 10,000 1,390,000 2,187,209 03/03/23
Hoge Stephen President President Feb 28 Sell 138.03 1,072 147,968 1,629,031 03/02/23
Hoge Stephen President President Feb 28 Option 0 2,410 1,630,103 03/02/23
AFEYAN NOUBAR Director Director Feb 15 Sell 173.17 10,000 1,731,700 2,207,209 02/17/23
Hoge Stephen President President Feb 09 Sell 163.9 245 40,156 1,627,693 02/13/23
Hoge Stephen President President Feb 09 Option 0 522 1,627,938 02/13/23
AFEYAN NOUBAR Director Director Feb 08 Sell 166.92 20,000 3,338,400 2,217,209 02/10/23
AFEYAN NOUBAR Director Director Jan 25 Sell 194.33 10,000 1,943,300 2,237,209 01/27/23
AFEYAN NOUBAR Director Director Jan 18 Sell 200.20 10,000 2,002,000 2,247,209 01/20/23
Bancel Stephane Chief Executive Offi.. Chief Executive Officer Jan 18 Sell 198.64 80,000 15,891,200 5,411,946 01/20/23
Bancel Stephane Chief Executive Offi.. Chief Executive Officer Jan 18 Option 0.99 80,000 79,200 5,451,946 01/20/23
AFEYAN NOUBAR Director Director Jan 11 Sell 188.57 10,000 1,885,700 2,257,209 01/13/23
Bancel Stephane Chief Executive Offi.. Chief Executive Officer Jan 11 Sell 184.24 80,000 14,739,200 5,411,946 01/13/23
Bancel Stephane Chief Executive Offi.. Chief Executive Officer Jan 11 Option 0.99 80,000 79,200 5,451,946 01/13/23
AFEYAN NOUBAR Director Director Jan 04 Sell 182.15 10,000 1,821,500 2,267,209 01/06/23